Scientists use new strategy to successfully shrink tumors in early brain cancer trials [Video]

A fresh approach to battling an aggressive form of brain tumor has shown promise in small-scale experiments involving a few patients.

Scientists transformed immune cells from the patients into “living drugs” capable of identifying and attacking glioblastoma, a type of brain cancer. Initial tests revealed that these cells managed to shrink tumors, albeit temporarily, as researchers reported on Wednesday.

While CAR-T therapy, used to combat blood-related cancers such as leukemia, has been effective, its application to solid tumors has posed challenges. However, teams at Massachusetts General Hospital and the University of Pennsylvania are working on improved CAR-T versions tailored to overcome glioblastoma’s defenses.

Dr. Stephen Bagley from the University of Pennsylvania, who spearheaded one of the studies, emphasized that it’s still early. Nevertheless, there’s optimism that this groundwork provides a solid foundation for further advancement.

What is Glioblastoma?

Glioblastoma, the type of brain cancer that claimed the lives of Beau Biden, son of President Joe Biden …